Jazz Pharmaceuticals plc
JAZZ NASDAQHealthcare ★★★★★Latest Earnings
Date
Aug 3, 2026
ET
EPS Est.
6.18
EPS Actual
5.71
Revenue Est.
$1.11B
Revenue Actual
$1.21B
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Your time zone matches ET
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
6.49
Revenue Est.
$1.21B
Company Overview
Jazz Pharmaceuticals plc (ticker JAZZ) is listed on NASDAQ with a market cap of about $15.97B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), After-market, with consensus EPS of 6.49. In the last 15 reported quarters, EPS beat consensus estimates 7 times.
Actual EPS TrendRecently15Term · Mar 1, 2023 → Aug 3, 2026
Mar 1, 2023Range: -8.25 ~ 8.13Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | 6.18 | 5.71 | $1.11B | $1.21B |
| May 5, 2026 | -- | 4.64 | Above forecast↑6.34 | $978.7M | $1.07B |
| Feb 24, 2026 | -- | 6.52 | 6.64 | $1.17B | $1.2B |
| Nov 5, 2025 | -- | 5.95 | Above forecast↑8.13 | $1.11B | $1.13B |
| Aug 5, 2025 | -- | -6.12 | Below forecast↓-8.25 | $1.05B | $1.05B |
| May 6, 2025 | -- | 4.51 | Below forecast↓1.68 | $1.06B | $897.8M |
| Feb 25, 2025 | -- | 5.83 | 6.60 | $985M | $1.09B |
| Nov 6, 2024 | -- | 5.47 | Above forecast↑6.61 | $1.06B | $1.05B |
| Jul 31, 2024 | -- | 4.68 | 5.30 | $1.04B | $1.02B |
| May 1, 2024 | -- | 4.14 | Below forecast↓2.68 | $954M | $902M |
| Feb 28, 2024 | -- | 5.26 | 5.02 | $957.3M | $1.01B |
| Nov 8, 2023 | -- | 4.90 | 4.84 | $1.01B | $972.1M |
| Aug 9, 2023 | -- | 4.46 | 4.51 | $942.9M | $957.3M |
| May 10, 2023 | -- | 4.26 | 3.95 | $943.9M | $892.8M |
| Mar 1, 2023 | -- | 0.51 | Below forecast↓-0.07 | $895.4M | $972.1M |
Original Filings (SEC)
Quarterly10-Q · 2026-08-03 ↗
Earnings Release8-K · 2026-08-03 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-05 ↗
Annual10-K · 2026-02-24 ↗
Earnings Release8-K · 2026-02-24 ↗
Quarterly10-Q · 2025-11-05 ↗
Earnings Release8-K · 2025-11-05 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
